Novelion Therapeutics Added to the Russell 3000® & Russell Microcap® Indexes
June 26, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, June 26, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association
June 12, 2017 08:30 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., June 12, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Novelion Therapeutics Appoints John J. Orloff, M.D., to Its Board of Directors, Steps Down as EVP, Head of R&D
June 01, 2017 16:01 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., June 01, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of...
Novelion Therapeutics Reports First Quarter 2017 Financial Results
May 09, 2017 07:00 ET
|
Novelion Therapeutics, Inc.
Global Expansion Plans for Metreleptin Opportunity to be Announced this Summer Defined Clinical Development Plan for Zuretinol Following Positive FDA MeetingCompany Reiterates FY 2017 Total Net...
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical Endocrinology
May 05, 2017 09:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia and CAMBRIDGE, Mass., May 05, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...
Novelion Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017
May 03, 2017 16:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, May 03, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals...
Novelion Therapeutics Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference
April 25, 2017 09:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, April 25, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics, Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for...
Novelion Therapeutics’ Request to Voluntarily Delist from the Toronto Stock Exchange Granted
April 19, 2017 16:15 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, April 19, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics, Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for...
Metreleptin and Lipodystrophy Data Presented at the Annual Meeting of the Endocrine Society
April 04, 2017 16:10 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia & CAMBRIDGE, Mass., April 04, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new...
Novelion Therapeutics Appoints Mark Corrigan, M.D. to Board of Directors
March 31, 2017 08:00 ET
|
Novelion Therapeutics, Inc.
VANCOUVER, British Columbia, March 31, 2017 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN) (TSX:NVLN), a biopharmaceutical company dedicated to developing new standards of care for...